News & Insights
Articles
October 29, 2026The Patent Cliff Is an Opening for Central and Eastern Europe Biotech — Readiness Will Decide Who Benefits
Sterne, Kessler, Goldstein & FoxArticles
October 27, 2026Where the Patents Are: IP Lessons for Solar’s Mounting and Tracking Innovators
Sterne, Kessler, Goldstein & FoxArticles
October 22, 2026Will Washington Regulate Biotech Licensing Like Semiconductors? Tracking BINSA and Treasury’s Next Move
Sterne, Kessler, Goldstein & FoxArticles
October 13, 2026Patent Claim Quality and Scope: Why What a Patent Claims Matters More Than Whether It Exists
Sterne, Kessler, Goldstein & FoxFirm News
October 6, 2026Sterne Kessler Advises IntraBio in $2 Billion Sale to Shionogi
Sterne, Kessler, Goldstein & FoxArticles
September 18, 2026Screening China-Origin Biotech IP: A New U.S.-EU Divide
Sterne, Kessler, Goldstein & Fox
Stay in the Know
Receive insights from the most respected practitioners of IP law, straight to your inbox.
Subscribe for Updates